Mu Cheng

Analysis Group

Poster(s):

• (A-335) Leveraging Real-World Data for Regulatory Commitment: Methodological Considerations in a Post-Approval Safety Study Evaluating the Risk of Atrial Fibrillation (AF) Following Respiratory Syncytial Virus (RSV) Vaccination
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET